forecasting and analytics
Today's business conditions require greater forecasting accuracy than ever before
Third party prescription audit data is increasingly susceptible to projection error due to falling Rx capture rates. Arms length relationships between manufacturers and retailers create a challenging environment for data fidelity and transparency. Dynamic inventory management and fee-for-service agreements combined with increasing retail and mail-order inventory volatility are all symptoms of today's challenging landscape of pharmaceutical demand forecasting.
On the operations side, tightened capital management requirements increases pressure on production planning, heightening the need for near term demand information. This growing need for accurate inventory accruals is also related to increased generic introductions, product recalls and evolving provider business practices.
How IntegriChain enhances forecasting and analytic accuracy
The Enriched Channel Sales™ reporting functions give you new levels of information to help manage your business more effectively.
- Quantify and monitor retail, mail order, and LTC inventory changes
- Monitor actual mail order and specialty pharmacy pull-through for 100% of providers
- Reconcile gross sales with prescription demand
- Quantify changes in third party audit projection errors within weeks of error change
- Determine sub-national impact of third party data errors
- Tighten accruals for total channel inventory exposure
Maximize the value of your existing assets
Your channel data investments contain vast untapped value. IntegriChain's unique products and services help you easily unlock the marketing value they represent, across the entire commercial organization.
Achieve additional business intelligence with high-powered guided analytics that deliver greater insight into manufacturers' direct data assets.
Get a high-resolution picture of long-term demand forecasting, short-term wholesale and retail inventories, and accurate total pipeline metrics.